logo
Plus   Neg
Share
Email

Stock Alert: Compugen Jumps 9%

Shares of Compugen Ltd. (CGEN) gained up 9% on Friday morning despite no stock-related news.

CGEN is currently trading at $13.93, up $1.10 or 8.57%, on the Nasdaq.

Compugen is a therapeutic company, which engages in the research, development, and commercialization of therapeutic and product candidates in Israel, the US, and Europe. The company's therapeutic pipeline consists of immuno-oncology programs against novel drug targets, including T cell immune checkpoints and other early-stage immuno-oncology programs focusing on myeloid target.

Early this month, the company announced that the FDA has cleared the investigational new drug application for its Phase 1/2 study evaluating the triple combination of COM701, with Bristol Myers Squibb's Opdivo and TIGIT antibody, in patients with advanced solid tumors.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Brazos Electric Power Cooperative Inc., the largest power generation and transmission cooperative in Texas, filed for Chapter 11 bankruptcy protection citing a huge bill from the state's grid operator following major outages recently amid the winter storm. Brazos received a $1.8 billion bill from electricity grid operator Electric Reliability Council of Texas or ERCOT. El Abuelito Cheese is recalling certain types of cheese and cheese products for fear of potential contamination with Listeria Monocytogenes, a deadly bacteria, the U.S. Food & Drug Administration said in a statement. The recall involves Queso Fresco (Fresh, soft cheese), Quesillo (Oaxaca, string cheese), and Requeson (Ricotta) products. Technology company CAE Inc. (CAE.TO, CAE) agreed Monday to acquire the military training division of aerospace and defense technology firm L3Harris Technologies Inc. (LHX) for $1.05 billion, subject to customary adjustments. The acquisition will expand CAE's position as a platform-agnostic training...
RELATED NEWS
Follow RTT